In addition, promising first in human (phase I) data are available for vibrotactile CR stimulation for the treatment of Parkinson's disease showing pronounced and highly significant sustained therapeutic effects (Syrkin-Nikolau et al., 2018 ).
← all excerpts
Short-Term Dosage Regimen for Stimulation-Induced Long-Lasting Desynchronization.
1
—
—